Vontobel Holding Ltd. Pmv Pharmaceuticals, Inc. Transaction History

Vontobel Holding Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jun 03, 2024	BUY	$1.23 - $6.6 $470,058 - $2.52 Million	382,161 Added 125.78%	685,985 $2.13 Million
Q4 2023 Jan 29, 2024	BUY	$1.23 - $6.6 $470,058 - $2.52 Million	382,161 Added 125.78%	685,985 $2.13 Million
Q3 2023 Jun 03, 2024	SELL	$6.01 - $8.93 $170,840 - $253,844	-28,426 Reduced 8.56%	303,824 $1.87 Million
Q3 2023 Oct 10, 2023	SELL	$6.01 - $8.93 $170,840 - $253,844	-28,426 Reduced 8.56%	303,824 $1.87 Million
Q2 2023 Jun 03, 2024	BUY	$3.94 - $6.27 $322,217 - $512,766	81,781 Added 32.65%	332,250 $2.08 Million
Q2 2023 Jul 24, 2023	BUY	$3.94 - $6.27 $322,217 - $512,766	81,781 Added 32.65%	332,250 $2.08 Million
Q1 2023 Jun 03, 2024	BUY	$4.77 - $9.16 $1.19 Million - $2.29 Million	250,469 New	250,469 $1.19 Million
Q1 2023 Apr 12, 2023	BUY	$4.77 - $9.16 $1.19 Million - $2.29 Million	250,469 New	250,469 $1.19 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $72.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.